BioXell Appoints Thomas Szucs as New Chairman of the Board of Directors
Thomas Szucs, chairman of Swiss life science investment company BB Biotech, has been a member of BioXell's Board of Directors since 2004. He is also Co-Chairman of the European Centre of Pharmaceutical Medicine at the University of Basel and leads health economic research and training at the Medical Faculty of the University of Zurich.
Werner Lanthaler, PhD, has been CFO at Vienna-based biotech company Intercell since 2001, where he has been instrumental in the growth of the company and its public listing early last year.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.